NERVE CONDUCTION STUDIES

This adverse event was reported 7 times

NERVE CONDUCTION STUDIES is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NIPOCALIMAB-AAHU 1 0.0031
1 ALENDRONATE SODIUM AND CHOLECALCIFEROL 1 0.0004
2 HUMAN INSULIN 1 0.0001
3 LIRAGLUTIDE 1 0.0000
4 MEPOLIZUMAB 1 0.0000
5 CIPROFLOXACIN TABLETS 1 0.0000
6 CIPROFLOXACIN HYDROCHLORIDE 1 0.0000
7 ALENDRONATE SODIUM 1 0.0000
8 PREDNISONE 1 0.0000
9 ETANERCEPT 1 0.0000
See all drugs enriched for association with NERVE CONDUCTION STUDIES

NERVE CONDUCTION STUDIES is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 1 0.0015
1 Insulin [EPC] 1 0.0000
2 Fluoroquinolone Antibacterial [EPC] 1 0.0000
3 Vitamin D [EPC] 1 0.0000
4 GLP-1 Receptor Agonist [EPC] 1 0.0000
5 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
6 Corticosteroid [EPC] 1 0.0000
See all drug classes enriched for association with NERVE CONDUCTION STUDIES